Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297

1.

Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1.

Smith-Anttila CJA, Bensing S, Alimohammadi M, Dalin F, Oscarson M, Zhang MD, Perheentupa J, Husebye ES, Gustafsson J, Björklund P, Fransson A, Nordmark G, Rönnblom L, Meloni A, Scott RJ, Hökfelt T, Crock PA, Kämpe O.

Autoimmunity. 2017 Jun;50(4):223-231. doi: 10.1080/08916934.2017.1332183. Epub 2017 May 30.

PMID:
28557628
2.

Autoantibodies Targeting a Collecting Duct-Specific Water Channel in Tubulointerstitial Nephritis.

Landegren N, Pourmousa Lindberg M, Skov J, Hallgren Å, Eriksson D, Lisberg Toft-Bertelsen T, MacAulay N, Hagforsen E, Räisänen-Sokolowski A, Saha H, Nilsson T, Nordmark G, Ohlsson S, Gustafsson J, Husebye ES, Larsson E, Anderson MS, Perheentupa J, Rorsman F, Fenton RA, Kämpe O.

J Am Soc Nephrol. 2016 Oct;27(10):3220-3228. Epub 2016 Mar 16.

3.

Transglutaminase 4 as a prostate autoantigen in male subfertility.

Landegren N, Sharon D, Shum AK, Khan IS, Fasano KJ, Hallgren Å, Kampf C, Freyhult E, Ardesjö-Lundgren B, Alimohammadi M, Rathsman S, Ludvigsson JF, Lundh D, Motrich R, Rivero V, Fong L, Giwercman A, Gustafsson J, Perheentupa J, Husebye ES, Anderson MS, Snyder M, Kämpe O.

Sci Transl Med. 2015 Jun 17;7(292):292ra101. doi: 10.1126/scitranslmed.aaa9186.

PMID:
26084804
4.

Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases.

Oftedal BE, Hellesen A, Erichsen MM, Bratland E, Vardi A, Perheentupa J, Kemp EH, Fiskerstrand T, Viken MK, Weetman AP, Fleishman SJ, Banka S, Newman WG, Sewell WA, Sozaeva LS, Zayats T, Haugarvoll K, Orlova EM, Haavik J, Johansson S, Knappskog PM, Løvås K, Wolff AS, Abramson J, Husebye ES.

Immunity. 2015 Jun 16;42(6):1185-96. doi: 10.1016/j.immuni.2015.04.021.

5.

Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.

Wolff AS, Sarkadi AK, Maródi L, Kärner J, Orlova E, Oftedal BE, Kisand K, Oláh E, Meloni A, Myhre AG, Husebye ES, Motaghedi R, Perheentupa J, Peterson P, Willcox N, Meager A.

J Clin Immunol. 2013 Nov;33(8):1341-8. doi: 10.1007/s10875-013-9938-6. Epub 2013 Oct 26.

PMID:
24158785
6.

BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.

Shum AK, Alimohammadi M, Tan CL, Cheng MH, Metzger TC, Law CS, Lwin W, Perheentupa J, Bour-Jordan H, Carel JC, Husebye ES, De Luca F, Janson C, Sargur R, Dubois N, Kajosaari M, Wolters PJ, Chapman HA, Kämpe O, Anderson MS.

Sci Transl Med. 2013 Oct 9;5(206):206ra139. doi: 10.1126/scitranslmed.3006998.

7.

IL-7 dysregulation and loss of CD8+ T cell homeostasis in the monogenic human disease autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Laakso SM, Kekäläinen E, Rossi LH, Laurinolli TT, Mannerström H, Heikkilä N, Lehtoviita A, Perheentupa J, Jarva H, Arstila TP.

J Immunol. 2011 Aug 15;187(4):2023-30. doi: 10.4049/jimmunol.1100212. Epub 2011 Jul 13.

8.

TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus.

Smith CJ, Oscarson M, Rönnblom L, Alimohammadi M, Perheentupa J, Husebye ES, Gustafsson J, Nordmark G, Meloni A, Crock PA, Kämpe O, Bensing S.

Scand J Immunol. 2011 Feb;73(2):147-53. doi: 10.1111/j.1365-3083.2010.02486.x.

9.

Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model.

Ahlgren KM, Moretti S, Lundgren BA, Karlsson I, Ahlin E, Norling A, Hallgren A, Perheentupa J, Gustafsson J, Rorsman F, Crewther PE, Rönnelid J, Bensing S, Scott HS, Kämpe O, Romani L, Lobell A.

Eur J Immunol. 2011 Jan;41(1):235-45. doi: 10.1002/eji.200939883. Epub 2010 Dec 3.

10.

Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population.

Laakso SM, Laurinolli TT, Rossi LH, Lehtoviita A, Sairanen H, Perheentupa J, Kekäläinen E, Arstila TP.

J Autoimmun. 2010 Dec;35(4):351-7. doi: 10.1016/j.jaut.2010.07.008.

PMID:
20805020
11.

Risk of autoimmune diabetes in APECED: association with short alleles of the 5'insulin VNTR.

Paquette J, Varin DS, Hamelin CE, Hallgren A, Kämpe O, Carel JC, Perheentupa J, Deal CL.

Genes Immun. 2010 Oct;11(7):590-7. doi: 10.1038/gene.2010.33. Epub 2010 Jun 10.

PMID:
20535137
12.

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.

Kisand K, Bøe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E, Perheentupa J, Erichsen MM, Bratanic N, Meloni A, Cetani F, Perniola R, Ergun-Longmire B, Maclaren N, Krohn KJ, Pura M, Schalke B, Ströbel P, Leite MI, Battelino T, Husebye ES, Peterson P, Willcox N, Meager A.

J Exp Med. 2010 Feb 15;207(2):299-308. doi: 10.1084/jem.20091669. Epub 2010 Feb 1.

13.

Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)--a diagnostic and therapeutic challenge.

Jääskeläinen J, Perheentupa J.

Pediatr Endocrinol Rev. 2009 Dec;7(2):15-28. Review.

PMID:
20118890
14.

Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.

Siikala E, Richardson M, Pfaller MA, Diekema DJ, Messer SA, Perheentupa J, Saxén H, Rautemaa R.

Int J Antimicrob Agents. 2009 Dec;34(6):607-9. doi: 10.1016/j.ijantimicag.2009.07.007. Epub 2009 Sep 11. No abstract available.

PMID:
19748230
15.

Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I.

Husebye ES, Perheentupa J, Rautemaa R, Kämpe O.

J Intern Med. 2009 May;265(5):514-29. doi: 10.1111/j.1365-2796.2009.02090.x. Review.

16.

gammadelta T cells develop independently of Aire.

Tuovinen H, Pöntynen N, Gylling M, Kekäläinen E, Perheentupa J, Miettinen A, Arstila TP.

Cell Immunol. 2009;257(1-2):5-12. doi: 10.1016/j.cellimm.2009.01.012. Epub 2009 Mar 3.

PMID:
19261265
17.

Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen.

Alimohammadi M, Dubois N, Sköldberg F, Hallgren A, Tardivel I, Hedstrand H, Haavik J, Husebye ES, Gustafsson J, Rorsman F, Meloni A, Janson C, Vialettes B, Kajosaari M, Egner W, Sargur R, Pontén F, Amoura Z, Grimfeld A, De Luca F, Betterle C, Perheentupa J, Kämpe O, Carel JC.

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4396-401. doi: 10.1073/pnas.0809986106. Epub 2009 Feb 26.

18.

Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems.

Fetissov SO, Bensing S, Mulder J, Le Maitre E, Hulting AL, Harkany T, Ekwall O, Sköldberg F, Husebye ES, Perheentupa J, Rorsman F, Kämpe O, Hökfelt T.

J Comp Neurol. 2009 Mar 1;513(1):1-20. doi: 10.1002/cne.21913.

PMID:
19107747
19.

AIRE regulates T-cell-independent B-cell responses through BAFF.

Lindh E, Lind SM, Lindmark E, Hässler S, Perheentupa J, Peltonen L, Winqvist O, Karlsson MC.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18466-71. doi: 10.1073/pnas.0808205105. Epub 2008 Nov 14.

20.

Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I.

Oftedal BE, Wolff AS, Bratland E, Kämpe O, Perheentupa J, Myhre AG, Meager A, Purushothaman R, Ten S, Husebye ES.

Clin Immunol. 2008 Oct;129(1):163-9. doi: 10.1016/j.clim.2008.07.002. Epub 2008 Aug 16.

PMID:
18708298
21.

Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole.

Rautemaa R, Richardson M, Pfaller M, Perheentupa J, Saxen H.

Scand J Infect Dis. 2008;40(11-12):904-7. doi: 10.1080/00365540802275853.

PMID:
18651265
22.

Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes.

Kisand K, Link M, Wolff AS, Meager A, Tserel L, Org T, Murumägi A, Uibo R, Willcox N, Trebusak Podkrajsek K, Battelino T, Lobell A, Kämpe O, Lima K, Meloni A, Ergun-Longmire B, Maclaren NK, Perheentupa J, Krohn KJ, Scott HS, Husebye ES, Peterson P.

Blood. 2008 Oct 1;112(7):2657-66. doi: 10.1182/blood-2008-03-144634. Epub 2008 Jul 7.

23.

Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.

Rautemaa R, Richardson M, Pfaller MA, Perheentupa J, Saxén H.

Diagn Microbiol Infect Dis. 2008 Oct;62(2):182-5. doi: 10.1016/j.diagmicrobio.2008.05.007. Epub 2008 Jul 1.

PMID:
18597968
24.

Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.

Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O.

N Engl J Med. 2008 Mar 6;358(10):1018-28. doi: 10.1056/NEJMoa0706487.

25.

Testis-expressed protein TSGA10 an auto-antigen in autoimmune polyendocrine syndrome type I.

Reimand K, Perheentupa J, Link M, Krohn K, Peterson P, Uibo R.

Int Immunol. 2008 Jan;20(1):39-44. Epub 2007 Nov 13.

PMID:
18000009
26.

Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.

Rautemaa R, Richardson M, Pfaller M, Koukila-Kähkölä P, Perheentupa J, Saxén H.

J Antimicrob Chemother. 2007 Oct;60(4):889-92. Epub 2007 Aug 17.

PMID:
17704513
27.

Pituitary autoantibodies in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).

O'Dwyer DT, McElduff P, Peterson P, Perheentupa J, Crock PA.

Acta Biomed. 2007;78 Suppl 1:248-54.

PMID:
17465338
28.

Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1.

Bensing S, Fetissov SO, Mulder J, Perheentupa J, Gustafsson J, Husebye ES, Oscarson M, Ekwall O, Crock PA, Hökfelt T, Hulting AL, Kämpe O.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):949-54. Epub 2007 Jan 10.

29.

A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Kekäläinen E, Tuovinen H, Joensuu J, Gylling M, Franssila R, Pöntynen N, Talvensaari K, Perheentupa J, Miettinen A, Arstila TP.

J Immunol. 2007 Jan 15;178(2):1208-15.

30.

Epitope mapping of human aromatic L-amino acid decarboxylase.

Bratland E, Wolff AS, Haavik J, Kämpe O, Sköldberg F, Perheentupa J, Bredholt G, Knappskog PM, Husebye ES.

Biochem Biophys Res Commun. 2007 Feb 16;353(3):692-8. Epub 2006 Dec 22.

PMID:
17194446
31.

Oral and oesophageal squamous cell carcinoma--a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I).

Rautemaa R, Hietanen J, Niissalo S, Pirinen S, Perheentupa J.

Oral Oncol. 2007 Jul;43(6):607-13. Epub 2006 Sep 25.

PMID:
16997613
32.

Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.

Meager A, Visvalingam K, Peterson P, Möll K, Murumägi A, Krohn K, Eskelin P, Perheentupa J, Husebye E, Kadota Y, Willcox N.

PLoS Med. 2006 Jul;3(7):e289.

33.

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Perheentupa J.

J Clin Endocrinol Metab. 2006 Aug;91(8):2843-50. Epub 2006 May 9.

PMID:
16684821
34.

Bone health in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED): findings in 25 adults.

Mäkitie O, Sochett EB, Bondestam S, Sipilä I, Perheentupa J.

Clin Endocrinol (Oxf). 2006 May;64(5):489-94.

PMID:
16649965
36.

Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease.

Sköldberg F, Rorsman F, Perheentupa J, Landin-Olsson M, Husebye ES, Gustafsson J, Kämpe O.

J Clin Endocrinol Metab. 2004 Apr;89(4):1636-40.

PMID:
15070923
37.

Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I.

Söderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E, Miettinen A, Eskelin P, Halonen M, Tuomi T, Gustafsson J, Husebye ES, Perheentupa J, Gylling M, Manns MP, Rorsman F, Kämpe O, Nilsson T.

J Clin Endocrinol Metab. 2004 Feb;89(2):557-62.

PMID:
14764761
38.

Mulibrey nanism: clinical features and diagnostic criteria.

Karlberg N, Jalanko H, Perheentupa J, Lipsanen-Nyman M.

J Med Genet. 2004 Feb;41(2):92-8.

39.

The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex.

Gylling M, Kääriäinen E, Väisänen R, Kerosuo L, Solin ML, Halme L, Saari S, Halonen M, Kämpe O, Perheentupa J, Miettinen A.

J Clin Endocrinol Metab. 2003 Oct;88(10):4602-8.

PMID:
14557429
40.

[Should we stop using the phrase "doctor's order"?].

Perheentupa J.

Duodecim. 2003;119(8):735. Finnish. No abstract available.

PMID:
12806731
41.

Mulibrey heart disease: clinical manifestations, long-term course, and results of pericardiectomy in a series of 49 patients born before 1985.

Lipsanen-Nyman M, Perheentupa J, Rapola J, Sovijärvi A, Kupari M.

Circulation. 2003 Jun 10;107(22):2810-5. Epub 2003 May 19.

PMID:
12756154
42.

Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells.

Sköldberg F, Portela-Gomes GM, Grimelius L, Nilsson G, Perheentupa J, Betterle C, Husebye ES, Gustafsson J, Rönnblom A, Rorsman F, Kämpe O.

J Clin Endocrinol Metab. 2003 Apr;88(4):1445-52.

PMID:
12679420
43.

[Overexploitation by Duodecim?].

Perheentupa J.

Duodecim. 2001;117(16):1680; author reply 1681. Finnish. No abstract available.

PMID:
12182107
44.

[Pediatric Research Foundation's research grants and efficiency of their use].

Perheentupa J.

Duodecim. 2001;117(11):1182-5. Finnish. No abstract available.

PMID:
12116719
45.

APS-I/APECED: the clinical disease and therapy.

Perheentupa J.

Endocrinol Metab Clin North Am. 2002 Jun;31(2):295-320, vi. Review.

PMID:
12092452
46.

AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype.

Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kämpe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J.

J Clin Endocrinol Metab. 2002 Jun;87(6):2568-74.

PMID:
12050215
47.

Epitope mapping of cytochrome P450 cholesterol side-chain cleavage enzyme by sera from patients with autoimmune polyglandular syndrome type 1.

Liiv I, Teesalu K, Peterson P, Clemente MG, Perheentupa J, Uibo R.

Eur J Endocrinol. 2002 Jan;146(1):113-9.

PMID:
11751076
48.

[Child health center as a promoter of children's health].

Saarelma O, Perheentupa J.

Duodecim. 1998;114(11):1065, 1067, 1069. Finnish. No abstract available.

PMID:
11544686
49.

Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Obermayer-Straub P, Perheentupa J, Braun S, Kayser A, Barut A, Loges S, Harms A, Dalekos G, Strassburg CP, Manns MP.

Gastroenterology. 2001 Sep;121(3):668-77.

PMID:
11522751
50.

The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I.

Hedstrand H, Ekwall O, Olsson MJ, Landgren E, Kemp EH, Weetman AP, Perheentupa J, Husebye E, Gustafsson J, Betterle C, Kämpe O, Rorsman F.

J Biol Chem. 2001 Sep 21;276(38):35390-5. Epub 2001 Jun 22.

Supplemental Content

Loading ...
Support Center